MedTrace Logo

Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis

NCT03841279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-04-13

No results posted yet for this study

Summary

MRI has been shown to be helpful in identifying patients who present with undifferentiated inflammatory arthritis who will develop RA within a one year follow up period. The absence of other clinically apparent symptoms often causes delays in diagnosis of RA. The use of the MRI in conjunction with the physical examination has the potential to reduce diagnostic delay. Earlier diagnosis would allow for earlier treatment implementation for better patient outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

Magnetic resonance imaging (MRI) produces detailed images of the body's internal structures without relying on radiation. It is used to diagnose and also gauge efficacy of treatment.

Sponsors & Collaborators

Principal Investigators

  • Kerry Wright, MBBS · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-06-17
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03841279 on ClinicalTrials.gov